DNA-Topoisomerase I, a new target for the treatment of neuroblastoma

Author： Vassal G.   Pondarre C.   Cappelli C.   Terrier-Lacombe M.J.   Boland I.   Morizet J.   Benard J.   Venuat A.M.   Ardouin P.   Hartmann O.   Gouyette A.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.12, 1997-10, pp. : 2011-2015

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topoisomerase I Inhibitors and Other New Cytotoxic Drugs

By Verweij J.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 828-830

Elsevier

Access to resources Recommend Favorite

Elevated Topoisomerase I Activity in Cervical Cancer as a Target for Chemoradiation Therapy

By Chen B.-M.   Chen J.-Y.   Kao M.   Lin J.-B.   Yu M.-H.   Roffler S.R.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 272-280

Elsevier

Access to resources Recommend Favorite

Topoisomerase I as a target of erlotinib and gefitinib: Efficacy of combined treatments with camptothecin

By      

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 934-942

Spandidos Publications

Access to resources Recommend Favorite

Development of DNA Topoisomerase-Related Therapeutics: A Short Perspective of New Challenges

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 4, 2004-07 ,pp. : 335-345

Bentham Science Publishers

Access to resources Recommend Favorite

Topoisomerase I Inhibitors in the Treatment of Primary CNS Malignancies: An Update on Recent Trends

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 9, 2010-01 ,pp. : 683-696

Bentham Science Publishers

Access to resources Recommend Favorite